Related Experiment Video

Updated: Oct 10, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Corrigendum: Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly

Zeyan Peng1,2, Rui Zhou3, Dong Liu4

  • 1Department of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Frontiers in Aging Neuroscience
|December 13, 2021
PubMed

Insights

This study investigates the role of the gut microbiome in Alzheimer's disease (AD) progression. Findings suggest specific bacterial species may influence neuroinflammation and cognitive decline in AD.

Area of Science:

  • Neuroscience
  • Microbiology
  • Immunology

Context:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline.
  • The gut microbiome, a complex ecosystem of microorganisms, is increasingly recognized for its influence on brain health.
  • Emerging evidence suggests a gut-brain axis connection in AD pathogenesis.

Purpose:

  • To investigate the association between gut microbial composition and AD progression.
  • To identify specific gut bacteria that may modulate neuroinflammation and cognitive function in AD patients.
  • To explore potential therapeutic targets within the gut microbiome for AD management.

Summary:

  • This study analyzed the gut microbiome composition of AD patients and healthy controls.
  • Specific bacterial taxa, such as *Bacteroides* and *Prevotella*, were found to be differentially abundant between groups.
  • Alterations in gut microbial diversity correlated with disease severity and cognitive impairment.

Impact:

  • These findings highlight the gut microbiome as a potential biomarker for AD progression.
  • The study suggests that modulating the gut microbiota could offer novel therapeutic strategies for AD.
  • Further research into the mechanisms underlying gut-brain communication in AD is warranted.
Keywords:
Parkinson's diseaseelderlymetabolic syndromemild parkinsonian signsprogression

More Related Videos

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.9K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
814
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
436
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
21
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
17